The clinical spectrum associated with pathogenic variants in DNM1 has been previously described [16], encompassing multiple typical manifestations with early onset (< 1 year), such as epilepsy, neurodevelopmental delay/arrest/regression, visual disturbances, movement disorders including choreoathetosis, dystonia and spasticity, and facial dysmorphism. This evidence concerns the gene DNM1 and epilepsy.